GRAFT SURVIVAL AFTER PENETRATING KERATOPLASTY

GRAFT SURVIVAL AFTER PENETRATING KERATOPLASTY
Arthur Cummings
Published: Monday, June 15, 2015

Graft-to-host transmission of herpes simplex virus (HSV) seems to represent a real phenomenon with the potential to have a major negative impact on graft survival after penetrating keratoplasy, according to Berthhold Seitz MD.
"To enable an appropriate prophylactic acyclovir treatment in distinct cases after PKP, we advocate the screening of patient and donor corneas for HSV-1 by use of polymerase chain reaction testing," he told the European Society of Ophthalmology meeting in Vienna.
Dr Seitz warned, however, that resistance to acyclovir may occur during long-term prophylaxis, especially in immuno-compromised patients.
 He noted that HSV is a very frequent cause of unilateral keratitis and is often a bilateral occurrence in childhood. 
"'Herpetic keratitis can be treated quite well given that the various forms of appearance are known and the therapeutic regimens both medical and surgical are adequately chosen," he said.
 

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...